Does LEVOLEUCOVORIN Cause Interstitial lung disease? 110 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Interstitial lung disease have been filed in association with LEVOLEUCOVORIN (Levoleucovorin). This represents 3.5% of all adverse event reports for LEVOLEUCOVORIN.
110
Reports of Interstitial lung disease with LEVOLEUCOVORIN
3.5%
of all LEVOLEUCOVORIN reports
59
Deaths
55
Hospitalizations
How Dangerous Is Interstitial lung disease From LEVOLEUCOVORIN?
Of the 110 reports, 59 (53.6%) resulted in death, 55 (50.0%) required hospitalization, and 14 (12.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOLEUCOVORIN. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOLEUCOVORIN Cause?
Diarrhoea (302)
Nausea (274)
Neutropenia (246)
Decreased appetite (223)
Neuropathy peripheral (178)
Neutrophil count decreased (176)
Pyrexia (175)
Vomiting (167)
Febrile neutropenia (130)
Off label use (125)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LEVOLEUCOVORIN Alternatives Have Lower Interstitial lung disease Risk?
LEVOLEUCOVORIN vs LEVOMEPROMAZINE
LEVOLEUCOVORIN vs LEVOMETHADONE
LEVOLEUCOVORIN vs LEVOMILNACIPRAN
LEVOLEUCOVORIN vs LEVONORGESTREL
LEVOLEUCOVORIN vs LEVORPHANOL